HC Wainwright Has Optimistic View of electroCore Q2 Earnings

electroCore, Inc. (NASDAQ:ECOR - Free Report) - HC Wainwright boosted their Q2 2025 earnings estimates for shares of electroCore in a report released on Wednesday, December 18th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.17) per share for the quarter, up from their prior estimate of ($0.19). HC Wainwright currently has a "Buy" rating and a $25.00 target price on the stock. The consensus estimate for electroCore's current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore's Q3 2025 earnings at ($0.14) EPS, Q4 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.60) EPS.

electroCore Stock Up 5.2 %

Shares of ECOR traded up $0.75 during trading hours on Friday, hitting $15.27. The company had a trading volume of 198,723 shares, compared to its average volume of 37,439. electroCore has a 52-week low of $5.25 and a 52-week high of $17.84. The stock's 50 day moving average price is $11.51 and its 200 day moving average price is $8.12. The firm has a market cap of $100.09 million, a P/E ratio of -8.34 and a beta of 0.57.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ECOR. Geode Capital Management LLC lifted its holdings in electroCore by 10.3% in the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company's stock worth $458,000 after buying an additional 5,951 shares during the period. HighTower Advisors LLC purchased a new stake in electroCore in the third quarter worth $255,000. International Assets Investment Management LLC boosted its holdings in electroCore by 689.1% in the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company's stock valued at $3,864,000 after acquiring an additional 467,326 shares in the last quarter. Finally, Renaissance Technologies LLC increased its position in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company's stock valued at $442,000 after purchasing an additional 2,270 shares during the period. Institutional investors own 26.74% of the company's stock.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.